Jayesh Desai

Has grant

Head, Early Drug Development

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Research Cancer Research professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Targeting BCL-2 in estrogen receptor positive breast cancer.

Open Date: 2019-01-01

Close Date: 2021-12-01

Grant: Close

Targeting BCL-2 in estrogen receptor positive breast cancer

Open Date: 2019-01-01

Close Date: 2021-12-01

Grant: Close

Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers

Open Date: 2018-01-01

Close Date: 2021-12-01

Grant: Close

Providing equitable, convenient and efficient access to novel cancer therapies: A Phase I outreach program

Open Date: 2017-01-01

Close Date: 2020-01-01

Grant: Close

Precision Medicine Program and Novel Clinical Trials

Open Date: 2017-01-01

Close Date: 2020-01-01

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

David Ritchie

Head of BMT

AUSTRALIA

View details

Jeremy Lewin

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Tarek Meniawy

University of Western Australia

AUSTRALIA

View details

David Gyorki

sir peter maccallum department of oncology university of melbourne melbourne victoria australia

AUSTRALIA

View details

Se Hyun Kim

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jayesh Desai

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial

Clinical activity in general practice before sarcoma diagnosis: an Australian cohort study

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

A first-in-human, phase 1a/1b, open-label, dose-escalation and expansion study to investigate the safety, pharmacokinetics, and antitumor activity of the RAF dimer inhibitor BGB-3245 in patients with advanced or refractory tumors

Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

CRESTONE: A Phase 2 study of seribantumab in adult patients with neuregulin-1 (NRG1) fusion positive locally advanced or metastatic solid tumors

Collaborators (5)

David Ritchie

Jeremy Lewin

Tarek Meniawy

David Gyorki

Se Hyun Kim

Make your next move.